RERAX
Price
$56.70
Change
+$0.12 (+0.21%)
Updated
Jul 3 closing price
Net Assets
134.48B
TIGCX
Price
$21.63
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Net Assets
730.49M
Interact to see
Advertisement

RERAX vs TIGCX

Header iconRERAX vs TIGCX Comparison
Open Charts RERAX vs TIGCXBanner chart's image
American Funds EUPAC R1
Price$56.70
Change+$0.12 (+0.21%)
VolumeN/A
Net Assets134.48B
Thornburg International Growth C
Price$21.63
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets730.49M
RERAX vs TIGCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RERAX vs. TIGCX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RERAX is a Buy and TIGCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 134B vs. TIGCX (730M). RERAX pays higher dividends than TIGCX: RERAX (0.23) vs TIGCX (0.00). RERAX was incepted earlier than TIGCX: RERAX (23 years) vs TIGCX (18 years). TIGCX (2.37) is less costly to investors than RERAX (1.57). TIGCX is a more actively managed with annual turnover of: 44.57 vs. RERAX (30.00). RERAX has a lower initial minimum investment than TIGCX: RERAX (250) vs TIGCX (5000). RERAX annual gain was more profitable for investors over the last year : 4.08 vs. TIGCX (-8.81). RERAX return over 5 years is better than : 12.35 vs. TIGCX (-9.61).
RERAXTIGCXRERAX / TIGCX
Total Expense Ratio1.572.3766%
Annual Report Gross Expense Ratio1.572.3766%
Fund Existence23 years18 years-
Gain YTD12.4338.967139%
Front LoadN/AN/A-
Min. Initial Investment25050005%
Min. Initial Investment IRAN/AN/A-
Net Assets134B730M18,356%
Annual Yield % from dividends0.230.00-
Returns for 1 year4.08-8.81-46%
Returns for 3 years26.8120.03134%
Returns for 5 years12.35-9.61-129%
Returns for 10 years21.0619.11110%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NMRA0.820.04
+5.04%
Neumora Therapeutics
OR26.030.44
+1.72%
OR Royalties Inc.
ZM78.580.99
+1.28%
Zoom Communications Inc
UWMC4.29N/A
N/A
UWM Holdings Corp
NLSP2.44-0.13
-5.06%
Nls Pharmaceutics Ltd